vNOTES Hysterectomy: What about Obese Patients?


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
07 2023
Historique:
received: 20 10 2022
revised: 15 03 2023
accepted: 19 03 2023
medline: 11 7 2023
pubmed: 27 3 2023
entrez: 26 3 2023
Statut: ppublish

Résumé

To compare the surgical outcomes of hysterectomy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) for patients with body mass index (BMI) <30 and BMI ≥30. A retrospective cohort study. A French teaching hospital. All patients who underwent a vNOTES hysterectomy from February 2020 to January 2022 were included (N = 200). The vNOTES approach was chosen for all patients requiring a hysterectomy, unless the procedure was for endometriosis or cancer (except grade 1 endometrioid adenocarcinoma). Patients were categorized into 2 groups based on their BMI (<30 or ≥30 kg/m A total of 146 patients were included in the BMI <30 group, and 54 patients in the BMI ≥30 group. There was no statistical difference between obese and nonobese patients concerning intraoperative conversion (p = .150), with 4 cases occurring in the BMI <30 group (2.74%) and 4 occurring in the BMI ≥30 group (7.41%). Operative times were longer in obese patients (115.93 min [±55.28] vs 79.78 min [±40.38], p <.001). There was no significant difference in blood loss (p = .337) or perioperative and postoperative complications (p = .346 and p = .612, respectively). The ability to complete the surgery as a same-day procedure was no different between obese and nonobese patients (p = .150). The results concerning intraoperative conversion and perioperative and postoperative complications show that vNOTES hysterectomies seem to be feasible for obese patients. When same-day surgery was decided before surgery, no more obese than nonobese patients were converted to conventional hospitalization. Further studies are needed to confirm these observations.

Identifiants

pubmed: 36966918
pii: S1553-4650(23)00112-7
doi: 10.1016/j.jmig.2023.03.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-575

Informations de copyright

Copyright © 2023 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Marie-Charlotte Bouchez (MC)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France. Electronic address: mariecharlotte_bouchez@yahoo.fr.

Victoire Delporte (V)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France.

Sophie Delplanque (S)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France.

Maxime Leroy (M)

Biostatistics Department (Ms. Leroy), CHU Lille, Lille, France.

David Vandendriessche (D)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France.

Chrystèle Rubod (C)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France.

Michel Cosson (M)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France.

Géraldine Giraudet (G)

Department of Gynecologic Surgery, Jeanne de Flandre Hospital (Drs. Bouchez, Delporte, Delplanque, Vandendriessche, Rubod, Cosson, and Giraudet), CHU Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH